Company / Capital Expenditures
PAVmed Inc. Capital Expenditures History
FY2021-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Capital Expenditures
$55.0K
FY2025
5-year range
$55.0K / $1.5M
FY2021-FY2025
Trend
-77.3%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Declined from $2M to $55,000 over the past 2 years.
Based on SEC 10-K filings.
$55,000 in FY2025 with a 3-year CAGR of -66.5%.
Declined from $2M to $55,000 over the past 2 years.
Capital Expenditures over time
Growth rates
- 3-Year CAGR
- -66.5%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- 3-year CAGR of -66.5%, indicating a declining trend.
- In FY2025, capital expenditures decreased 77.3% year-over-year.
- Peak capital expenditures was recorded in FY2023.
Company context
Key Data Points
- Altman Z-Score -0.77 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Capital ExpendituresValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $55.0K | -77.3% |
| FY2024 | $242.0K | -84.3% |
| FY2023 | $1.5M | +4.8% |
| FY2022 | $1.5M | +2570.9% |
| FY2021 | $55.0K | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026